Anti-HIV-1 activity, toxicity, and stability studies of representative structural families of polyoxometalates
- 1 October 1990
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 33 (10) , 2767-2772
- https://doi.org/10.1021/jm00172a014
Abstract
The anti-HIV-1 activity and toxicity of representative structural families of polyoxotungstates in human lymphocytes was determined. The 21 compounds examined include those derived from the following structural families: [NaSb9W21O86]18- (HPA-23), Xn+W12O40(8-n)- (Keggin), P2W18O626- (Wells-Dawson), W6O192- (Lindqvist), [NaP5W30O110]14- (Preyssler), and W10O324- (decatungstate). The molecular architecture of each of these structural families is constituted principally by a network of bonds between d0 WVI and oxide ions. Of these, 10 show median effective concentration (EC50) values of approximately 1 .mu.M and six have marked toxicity with a median inhibitory concentration (IC50) of less than 50 .mu.M. Only compounds containing more than six metal atoms showed appreciable antiviral activity. Beyond this, however, no marked correlation existed between the molecular size, charge, or charge density of the polyoxometalates and their anti-HIV-1 activity. Examination of an exemplary class of polyoxotungstates, the phosphotungstates of formula A- and B-PW9O349- under physiological conditions (buffered neutral aqueous media), illustrates that both isomers equilibrate rapidly to generate the same distribution of products and that this distribution depends principally on the buffer. These heretofore unappreciated complexities in the chemistry of these compounds under neutral aqueous conditions indicates interpretation or evaluation of these compounds in cell culture and other biological screens must be done with care.This publication has 4 references indexed in Scilit:
- Clinical trial of tolerance of HPA-23 in patients with acquired immune deficiency syndromeAntimicrobial Agents and Chemotherapy, 1988
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985
- Vibrational investigations of polyoxometalates. 3. Isomerism in molybdenum(VI) and tungsten(VI) compounds related to the Keggin structureInorganic Chemistry, 1984
- The antiviral compound HPA-23 can prevent scrapie when administered at the time of infectionArchiv für die gesamte Virusforschung, 1983